Skip to main content
Loading

Demonstrating efficacy and value for one-and done therapies

25 Sep 2024
Gene Therapy Development
  • How to overcome immunological barriers in AAV gene therapy?
  • How to minimize genotoxicity in high dose treatments?
  • How to improve cost/benefit ratio of gene therapy products?
Industry Expert
William Sun, Director - Vaxart